Prospective One-Year Outcomes of Preserflo MicroShunt Implantation in Glaucoma Following Keratoplasty.
Bolek Bartłomiej, Wylęgała Adam, Wylęgała Edward
Preserflo MicroShunt effectively lowered IOP and medication burden in post-keratoplasty glaucoma, with 84.2% qualified success. Crucially, it maintained corneal graft integrity (no VA/ECD change), making it a safe, effective option.